Scientists have sequenced the genome of the spontaneously hypertensive rat, which could help understand causes of the disease in humans.

( Cold Spring Harbor Laboratory ) Chronic high blood pressure, also known as hypertension, is a serious health risk factor that afflicts more than 25 percent of all adults worldwide, but the molecular basis of the disease remains poorly understood. In a study published online today in Genome Research, scientists have sequenced the genome of the spontaneously hypertensive rat, building a rich ...

Fitzgibbon Hospital and the Buckner Wellness Center will host another monthly education opportunity for the public beginning at 2 p.m. Wednesday, May 5, in the classroom suite on the second floor at Fitzgibbon Hospital.

Takeda Pharmaceutical Company Limited (Takeda) announced that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan ...

VIVUS, Inc. today announced that data on Qnexa®, an investigational drug candidate, will be presented at the American Society of Hypertension 25th Annual Scientific Meeting and Exposition in New York, NY.